Senseonics to Participate in Upcoming November Investor Conferences
November 08 2021 - 4:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and commercialization
of long-term, implantable continuous glucose monitoring (CGM)
systems for people with diabetes, today announced plans to
participate in two upcoming investor conferences.
Stifel 2021 Virtual Healthcare Conference Management will
participate in a virtual fireside chat on Tuesday, November 16,
2021 at 8:40am ET.
Jefferies London Healthcare Conference A presentation
from management will be made available on Thursday, November 18,
2021 at 3:00am ET.
Interested parties may access these live and on-demand webcasts
on the “Investors” section of the Company’s website at
www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211108005873/en/
Senseonics Investor Relations Contact: Lynn Lewis or
Philip Taylor Investor Relations 415-937-5406
Investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From May 2024 to Jun 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jun 2023 to Jun 2024